Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9M4T

CryoEM structure of the alpha1AAR complex with silodosin

This is a non-PDB format compatible entry.
Summary for 9M4T
Entry DOI10.2210/pdb9m4t/pdb
EMDB information63629
DescriptorAlpha-1A adrenergic receptor, Silodosin (2 entities in total)
Functional Keywordsgpcr, alpha1aar, silodosin, membrane protein
Biological sourceHomo sapiens (human)
Total number of polymer chains1
Total formula weight36288.03
Authors
Liu, S.S.,Guo, Q.,Wang, D.D.,Tao, Y.Y.,Jiao, H.Z. (deposition date: 2025-03-04, release date: 2025-07-02)
Primary citationLiu, S.,Jiao, H.,Tao, Y.,Wang, D.,Guo, Q.
Molecular mechanism of antagonist recognition and regulation of the alpha1A-adrenoceptor
J.Biol.Chem., :110348-110348, 2025
Cited by
PubMed Abstract: The α-adrenoceptor (αAR) is a critically important class of G protein-coupled receptors (GPCRs), comprising three subtypes: αAR, αAR, and αAR. Currently, drugs targeting αAR have been used in the treatment of various diseases. Notably, antagonists of αAR play a pivotal role in the management of benign prostatic hyperplasia (BPH). In recent years, researchers have developed selective antagonists for the αAR subtype that have a minimal impact on blood pressure for the treatment of BPH. However, these agents still exhibit certain side effects, necessitating the continuous development of new medications to mitigate adverse reactions while achieving more precise regulation. We report the cryo-EM structures of the αAR selective antagonist doxazosin and the αAR subtype selective antagonist silodosin in complex with αAR, demonstrating that M292 and V185 are key residues that confer subtype selectivity to silodosin. Additionally, modifications to αAR enhanced silodosin's inhibitory efficacy against αAR. These findings deepen our understanding of the recognition patterns of αAR antagonists, revealing the molecular principles underlying the selective binding of silodosin to αAR and promoting further research and development of subtype selective drugs targeting αAR.
PubMed: 40484377
DOI: 10.1016/j.jbc.2025.110348
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.19 Å)
Structure validation

238268

数据于2025-07-02公开中

PDB statisticsPDBj update infoContact PDBjnumon